About us
News & events
ImpactDiscoveryProductsAbout usNews & eventsInvestors
Our companyLeadershipCareersContact us
In the mediaPress releasesEventsBlog

A healthcare technology company accelerating medical research and improving patient care

Designed by clinicians, focused on patients, powered by AI.

We combine clinical artificial intelligence technology and ethically sourced, anonymised patient data to help people everywhere get better care.

To do this, we have created a unique partnership with the NHS that unlocks the value of electronic patient record data for research while safeguarding patient privacy. Alongside this we develop clinically validated software applications that create clinician and patient benefit while providing highly curated data.

Our business aims to have a double bottom line, providing an attractive return to our shareholders and making a positive social impact; improving health and generating wealth that we share with our NHS Trust partners and the University of Oxford.

Data is our NHS’ most precious asset – the next Prime Minister must protect it

Read Article

Our Process

Icon of a clinician

Patients and clinicians use our medical software, which is clinically proven to improve outcomes.

Icon of a clinician

Our software collects data on the care of patients in the real world which is then anonymised.

Icon of anonymised patient data

We combine this anonymised patient data with other data to create phenotypic datasets of value for discovery research.

Icon of AI

We use A.I. to analyse the data & answer clinically relevant questions and generate new discovery hypotheses.

Icon of microscope

This enables improvements in pharmaceutical development and clinical trials...

Icon of medication

... and the discovery of new medicines that further improve patient outcomes.

Our Products

We develop clinically validated software applications powered by artificial intelligence including prescribed digital therapeutics and hospital systems for clinical care. Our products connect patients, clinicians and researchers, generating large databases of phenotypic data, enabling discovery research and improving patient outcomes.

We have developed four clinically validated products (SEND, GDm-Health, EDGE and Support-HF) in collaboration with the University of Oxford and Oxford University Hospitals NHS Foundation Trust and one product (CleanSpace) for air pollution monitoring that has been validated by the National Physical Laboratory.

Photo of SEND app on an iPad
SEND app icon

Early Warning System

SEND is a system for monitoring patient vital signs in hospital.

Find out more
GDm-Health app icon

Gestational Diabetes

GDm-Health is a prescribed digital therapeutic for the management of gestational diabetes at home.

Find out more
GDm-Health app on an iPhone X
EDGE app on an iPad
EDGE app icon

COPD management

EDGE is a prescribed digital therapeutic for monitoring chronic obstructive pulmonary disease (COPD) at home.

Find out more
CleanSpace app icon

Air Pollution Monitoring

CleanSpace is a system for monitoring personal exposure to air pollution.

Find out more
CleanSpace app on an iPhone x
EDGE app on an iPad
EDGE app icon

Heart Failure Management

Support-HF is a prescribed digital therapeutic for monitoring heart failure at home

Find out more
EXPLORE
NHS data for researchClinical AI expertiseStrategic Research AgreementsCareersContact us
Further links
EventsBlogPress releasesLAB10x
Follow US
LinkedInTwitter
Legal
Privacy policyTerms & conditionsCookie policy
Contact
Sensyne Health plc
Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE
info@sensynehealth.com
+44 (0) 330 058 1845

© 2019 Sensyne Health plc. All rights reserved.
Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451
Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.
Note: Not all Sensyne Health products are available in all geographies, for further information contact head office.